Trials / Completed
CompletedNCT02495051
Esophageal Atresia: Metaplasia, Barrett
Prevalence of Barrett's Esophagus in Adolescents and Young Adults With Esophageal Atresia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 15 Years – 19 Years
- Healthy volunteers
- Not accepted
Summary
The frequency of Barrett's esophagus (BE) has increased in adults in the last decades, but BE is rare in children. Esophageal atresia (EA), the most common congenital anomaly affecting the esophagus, predisposes the patient to severe and prolonged gastroesophageal reflux disease. Because gastroesophageal reflux disease plays a major role in the development of BE by causing repeated mucosal damage, development of BE is a concern even in children and young adults in this specific population. The aim of this study is to assess the prevalence of BE (gastric and/or intestinal metaplasia) in a population of adolescents/young adults who had been treated for EA in early infancy. All eligible patients received upper gastrointestinal endoscopy under general anesthesia with standardized esophageal staged biopsies. Histological suspicion of metaplasia was confirmed centrally.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | esophageal biopsies |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2015-07-13
- Last updated
- 2015-07-13
Locations
20 sites across 4 countries: Belgium, Canada, France, Luxembourg
Source: ClinicalTrials.gov record NCT02495051. Inclusion in this directory is not an endorsement.